Feature Article

Artificial Intelligence in Prostate Cancer Diagnosis and Management: State-of-the-Art Approaches and Emerging Innovations

Abstract: Artificial intelligence (AI) is rapidly changing the field of medicine, and prostate cancer is no exception. The significant heterogeneity that characterizes the natural history of […]

Advances in Drug Development

Management of Toxicities Due to Immune Checkpoint Inhibitors

H&O Could you briefly describe your background and expertise in immune checkpoint inhibitors (ICIs)? PR I am a rheumatologist and clinical immunologist, and a graduate of […]

Highlights

Highlights in Gynecologic Cancer

From the 2026 American Society of Clinical Oncology Annual Meeting June 3-7, 2026 • Chicago, Illinois Selected by Ursula A. Matulonis, MD Pembrolizumab Plus Chemotherapy […]

CLL in Focus

Involvement of the Central Nervous System in CLL

H&O How commonly does chronic lymphocytic leukemia (CLL) spread to the central nervous system (CNS)? TC Our study found a prevalence of CNS involvement in CLL […]

Genitourinary Cancer in Focus

The Microbiome in Kidney Cancer

H&O Does the microbiome in the skin or gut of patients with kidney cancer differ from that of persons without the disease? SB We do not […]

Advances in LLM

Could Bispecific Antibodies Be Used as Consolidation Treatment After R-CHOP for DLBCL?

H&O What options are available for consolidation treatment after R-CHOP? ML We have good data regarding the use of radiotherapy after rituximab plus cyclophosphamide, doxorubicin, vincristine, […]

Letter From the Editor

Letter From the Editor: Hope Before the Data Catch Up

On the ninth floor of Duke University Hospital are our inpatient cancer wards. I don’t attend on the solid tumor service anymore, but I still recall […]